Gingival Enlargement in Patients who Have Undergone Renal Transplants: A Meta-Analysis
dc.authorid | Özveren, Neslihan/0000-0002-1090-5415; | |
dc.authorwosid | Özveren, Neslihan/AAO-4681-2020 | |
dc.authorwosid | Serindere, Gozde/HPH-0265-2023 | |
dc.contributor.author | Serindere, Gozde | |
dc.contributor.author | Ozveren, Neslihan | |
dc.date.accessioned | 2024-06-12T10:59:06Z | |
dc.date.available | 2024-06-12T10:59:06Z | |
dc.date.issued | 2018 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Severe gingival enlargement (GE) is one of the most commonly observed adverse effects in patients who have undergone renal transplants due to the use of cyclosporine A. Objectives: We aimed to gain more insight into the prevalence of GE in patients with renal transplants. Methods: We searched the PubMed and Web of Science databases for relevant studies from January 1990 to January 2018. Using random effects models, we calculated summary incidence rates and 95% confidence intervals (CIs). Results: A total of 595 patients from 10 studies were included. Patients using cyclosporine A with or without any other drugs had a 62.6% (95% CI, 41.9%-79.5%) incidence of GE. Subgroup analysis according to diagnostic criteria showed that the incidence of GE was lower when using well-defined diagnostic criteria or scoring system. The incidence of GE was 88.2% (95% CI, 80.9%-93.0%) in patients using cyclosporine A with nifedipine. Cyclosporine A without nifedipine was associated with a significantly decreased risk of GE incidence when compared with the combination of cyclosporine A and nifedipine (odds ratio: 0.198; 95% CI, 0.083-0.473; P < 0.001). Conclusions: It is important for all clinicians to know the effects of the aforementioned drugs and the treatment options. | en_US |
dc.identifier.doi | 10.14693/jdi.v25i2.1231 | |
dc.identifier.endpage | 120 | en_US |
dc.identifier.issn | 1693-9697 | |
dc.identifier.issn | 2355-4800 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 114 | en_US |
dc.identifier.uri | https://doi.org/10.14693/jdi.v25i2.1231 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20307 | |
dc.identifier.volume | 25 | en_US |
dc.identifier.wos | WOS:000448648700008 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Univ Indonesia, Fac Dentistry | en_US |
dc.relation.ispartof | Journal Of Dentistry Indonesia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cyclosporine A | en_US |
dc.subject | Gingival Enlargement | en_US |
dc.subject | Gingival Overgrowth | en_US |
dc.subject | Renal Transplantation | en_US |
dc.subject | Cyclosporine-A | en_US |
dc.subject | Allograft Recipients | en_US |
dc.subject | Overgrowth | en_US |
dc.subject | Nifedipine | en_US |
dc.subject | Hyperplasia | en_US |
dc.subject | Children | en_US |
dc.subject | Parameters | en_US |
dc.subject | Severity | en_US |
dc.title | Gingival Enlargement in Patients who Have Undergone Renal Transplants: A Meta-Analysis | en_US |
dc.type | Article | en_US |